Pro Tip: Learn how to use HBI Alerts to follow your favorite topics

Presentations at HBI Events

 

HBI 2022: Rosy future for dentistry, despite resurfacing threats

Pre-Covid, dentistry was seen as one of the hot tickets of healthcare services, largely unconsolidated, and attracting huge interest, not least from private equity. Covid took its toll but as the threat from the pandemic recedes in Europe, the focus has shifted back onto the opportunities in the sector – and onto other, longer-lasting problems like staffing, training, and the threat of recession. Despite these threats, according to a panel at HBI 2022, the future for the sector looks bright.

HBI 2022: Resilient fertility a “ridiculously positive market”

Resilient, recession-proof fertility has a strong future ahead, but will face some challenges in the coming months according to an HBI 2022 panel. Demand is strong, patients came back quickly when clinics - and borders - reopened, and the threat of recession is not causing anyone to lose sleep. 

HBI 2022: Panel sees a rosy future for ophthalmology

Ophthalmology continues to be a big area of investor interest, with considerable scope for consolidation in both healthcare services and also medical devices. As governments in the UK, Finland and parts of Eastern Europe in particular continue to increase outsourcing, the potential to unlock additional private pay services is increasing, and upselling of more complex lenses is on the rise. An expert panel convened at HBI 2022 to discuss the opportunities and challenges in the post-pandemic landscape.

HBI 2022: Balance of power in MENA is shifting

There is a risk, when looking at healthcare markets in MENA, of lumping all the countries together as one - but each market has very specific requirements, and very specific characteristics. A panel at HBI 2022 chaired by Hamid Yunis, partner at global law firm McDermott Will & Emery, investigated challenges and opportunities in the region - and how rapidly the markets are changing and why overseas players now need to work harder to impress.

HBI 2022: Dementia care clearly insufficient

The inexorable rise in the need for dementia care dominated the elderly care panel discussion at HBI 2022, whilst the global staffing crisis was also, inevitably, on the agenda. Is enough being done to prepare for the sharp rise in dementia patients expected in the coming years, and how are groups dealing with the war for talent? 

HBI 2022: M&A may slow in H2, but demand remains strong

“We are about to face a global recession,” conceded Hedley Goldberg, managing director at financial advisory group Rothschild, to a packed out audience at the plenary session on the M&A landscape at HBI 2022. “But it will be an unusual one with high levels of inflation and employment.”

HBI 2022: Trade associations preferred way for sector to defend itself

There were some eye catching audience poll results at the start of the Regulatory and Political Risk session at HBI 2022. A significant majority thought recent negative media coverage of for-profit health and care providers had impacted investor confidence - and that it would lead to new regulations.

HBI 2022: Is healthcare financially sustainable?

Daniela Hommel, CFO at healthcare communications firm Helios Global Health, starkly laid out the problem facing the healthcare sector at HBI 2022: “Healthcare is not financially sustainable if it continues along current trends. By 2050, 25% of GDP will have to go towards healthcare if these trends continue. This is not financeable."

Find Us